Is Edwards Lifesciences Pumping Up To Break Out?
While biotech and medical stocks got mauled after Hillary Clinton accused Big Pharma of price gouging, Edwards Lifesciences remained relatively unscathed. Large investors pumped up the leader in heart valve technology to a 13% gain last week. Will it now break out of its early-stage base?